Molecular structure of Butabindide oxalate, CAS Number: 185213-03-0
Butabindide oxalate (CAS 185213-03-0)
See product citations (1)
Application:
Butabindide oxalate is a selective and potent inhibitor of tripeptidyl peptidase II.
CAS Number:
185213-03-0
Purity:
≥98%
Molecular Weight:
393.44
Molecular Formula:
C17H25N3O2•C2H2O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Butabindide oxalate is a selective and potent inhibitor of TPPII (tripeptidyl peptidase II). TPP II is an enzyme involved in the breakdown of proteins, specifically targeting tripeptides for cleavage, which plays a part in the broader system of protein degradation and turnover within cells. By inhibiting TPP II, butabindide oxalate can influence protein processing and degradation pathways, shedding light on the complex mechanisms of intracellular protein regulation. This compound′s selective inhibition of TPP II makes it valuable in biochemical research, particularly in studies aiming to dissect the role of protein degradation in cellular physiology and the maintenance of cellular homeostasis.
Butabindide oxalate (CAS 185213-03-0) References
- Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors. | Ganellin, CR., et al. 2000. J Med Chem. 43: 664-74. PMID: 10691692
- A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. | Reits, E., et al. 2004. Immunity. 20: 495-506. PMID: 15084277
- Tripeptidyl peptidase II. An oligomeric protease complex from Arabidopsis. | Book, AJ., et al. 2005. Plant Physiol. 138: 1046-57. PMID: 15908606
- ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. | Schnurr, M., et al. 2009. J Immunol. 182: 1253-9. PMID: 19155470
- Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery. | Robson, NC., et al. 2010. Blood. 116: 218-25. PMID: 20430956
- Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire. | Oliveira, CC., et al. 2014. Mol Immunol. 62: 129-36. PMID: 24983205
- Dual proteolytic pathways govern glycolysis and immune competence. | Lu, W., et al. 2014. Cell. 159: 1578-90. PMID: 25525876
- Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells. | Baleeiro, RB., et al. 2015. Oncoimmunology. 4: e1047585. PMID: 26985398
- Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway. | Lirussi, D., et al. 2017. EBioMedicine. 22: 100-111. PMID: 28754303
- A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport. | Shlevkov, E., et al. 2019. Cell Rep. 28: 3224-3237.e5. PMID: 31533043
- Insights into the Molecular Basis of Genome Stability and Pristine Proteostasis in Naked Mole-Rats. | Narayan, V., et al. 2021. Adv Exp Med Biol. 1319: 287-314. PMID: 34424521
- Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. | Rose, C., et al. 1996. Nature. 380: 403-9. PMID: 8602240
- Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster. | Renn, SC., et al. 1998. J Biol Chem. 273: 19173-82. PMID: 9668104
Inhibitor of:
Protease, and TPPII.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Butabindide oxalate, 10 mg | sc-361130 | 10 mg | $189.00 | |||
Butabindide oxalate, 50 mg | sc-361130A | 50 mg | $770.00 |